Background: Continuous positive airway pressure (CPAP) has become a preferred method of respiratory support to preterm infants, especially those with birth weights <1250 g. In a study by Sreenan et al ...

May 18, 2005 (Washington) — Nasal continuous positive airway pressure (nCPAP) can be safely used in premature infants as an alternative to mechanical ventilation for babies with bronchopulmonary ...

May 16, 2010 — A new, randomized, multicenter trial has found no significant difference in the rate of death or bronchopulmonary dysplasia between premature babies receiving early continuous positive ...

The first clinical study of a low-cost neonatal breathing system demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent. A ...

More than 10 percent of newborns who receive oxygenation and ventilation using nasal continuous airway pressure in the neonatal intensive care unit (NICU) may experience complications inside or ...

Nasal continuous positive airway pressure (CPAP) therapy is a nonsurgical treatment that provides a steady flow of air to the lungs through the nose. Nasal CPAP is a common treatment for those with ...

The global neonatal intensive care respiratory devices market is expected to grow at a CAGR of ~6% during the forecast period. Rising incidence of preterm births and associated respiratory ...

The global neonatal intensive care respiratory devices market is projected to expand at a steady CAGR of nearly 6% over the forecast period. This growth is largely fueled by the rising number of ...